Company intelligence / Profile preview

BN ImmunoTherapeutics

Mountain View, California, USAbavarian-nordic.com ↗
Ownership
Private
Employees
~2
Development stage
Commercial
01

Overview

BN ImmunoTherapeutics developed recombinant poxvirus-based therapeutic vaccines for oncology indications. Its lead programs included a HER2-targeted breast cancer vaccine and a PSA-targeted prostate cancer vaccine. Both advanced into early-stage clinical trials to assess safety, tolerability, immune response generation, and preliminary efficacy signals. No recent updates suggest ongoing independent activity.

Therapeutic areas
Oncology
Modalities
Recombinant viral vector vaccinesCancer immunotherapiesCancer vaccines
Industry
Biotech
02

Drug pipeline

2 assets

Smallpox/Mpox vaccine

Commercial
Indications
Smallpox, Mpox

1 more asset in the full pipeline.

Request access →
03

Partnerships

No specific partnerships listed for the subsidiary beyond its integration with Bavarian Nordic’s broader collaborations with pharma companies like AstraZeneca on immunotherapy combinations at the group level

Beyond the preview

Go deeper on BN ImmunoTherapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BN ImmunoTherapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call